Trial intelligence / Profile preview

Butorphanol pretreatment to reduce sufentanil-induced cough and postoperative pain in elderly surgical patients

ChiCTR2100051150Phase 4Completed

Sponsor
West China Hospital of Sichuan University
Start
Sep 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of butorphanol in postoperative pain and cough (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Incidence of cough induced by sufentanil injection within 1 minute. Started Sep 2021; status: completed.

02

Drugs

butorphanol
03

Conditions

postoperative paincough

Beyond the preview

Go deeper on ChiCTR2100051150.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100051150.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call